Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002103550 | SCV002384892 | likely benign | Long QT syndrome | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372916 | SCV002688530 | likely benign | Cardiovascular phenotype | 2017-04-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002499938 | SCV002806261 | likely benign | Long QT syndrome 13; Familial hyperaldosteronism type III | 2021-10-07 | criteria provided, single submitter | clinical testing |